Noranelle (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol (an estrogen) and levonorgestrel (a progestogen) suppress the release of luteinizing hormone and follicle‑stimulating hormone, preventing ovulation. They also thicken cervical mucus and modify the endometrial lining, creating an environment that is hostile to sperm and implantation.

The dosing regimen for Noranelle is determined by the prescribing healthcare professional. Typically, it involves taking one tablet daily for a defined cycle, but the exact schedule and any missed‑dose instructions must be provided by the prescriber.

Noranelle is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy because it may cause fetal harm. It is also not recommended for use while breastfeeding, as hormone exposure could affect the infant.

To order Noranelle, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noranelle contains a specific dose combination of ethinylestradiol and levonorgestrel that offers contraceptive efficacy comparable to other combined oral contraceptives. Differences among products generally relate to hormone dose, pill formulation, and individual tolerability, which can influence side‑effect profiles and user preference.

Store Noranelle at ambient temperature, preferably below 25 °C. Keep the tablets in their original blister pack, protect them from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.

Noranelle is taken orally as a tablet. The usual instruction is to swallow one tablet each day, at the same time each day, with or without food, following the cycle schedule prescribed by the healthcare provider.

The most serious risks include thromboembolic events such as deep‑vein thrombosis and pulmonary embolism, as well as arterial events like stroke and myocardial infarction. Severe allergic reactions (anaphylaxis) and rare hepatic complications are also reported and require immediate medical attention.

Noranelle should not be used by women who are pregnant, have a history of blood‑clotting disorders, uncontrolled hypertension, severe liver disease, or who smoke cigarettes and are over 35 years old. It is also contraindicated in individuals with known hypersensitivity to either active ingredient.